Equities

Zeria Pharmaceutical Co Ltd

4559:TYO

Zeria Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,241.00
  • Today's Change18.00 / 0.81%
  • Shares traded30.60k
  • 1 Year change-3.41%
  • Beta0.3270
Data delayed at least 20 minutes, as of Sep 20 2024 02:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments20,32416,21911,704
Total Receivables, Net21,08017,42016,153
Total Inventory14,49012,76411,951
Prepaid expenses------
Other current assets, total1,9151,8011,856
Total current assets57,80948,20441,664
Property, plant & equipment, net26,51824,59123,139
Goodwill, net33,75933,45733,370
Intangibles, net9,3808,4737,836
Long term investments9,1456,8497,006
Note receivable - long term------
Other long term assets401396423
Total assets150,534135,035124,282
LIABILITIES
Accounts payable3,2741,9962,050
Accrued expenses1,5851,5551,531
Notes payable/short-term debt29,94229,47028,430
Current portion long-term debt/capital leases8,6905,6925,643
Other current liabilities, total11,0288,4456,540
Total current liabilities54,51847,15844,193
Total long term debt8,95415,54919,218
Total debt47,58650,71253,291
Deferred income tax6,4475,1913,905
Minority interest206231198
Other liabilities, total7851,4561,873
Total liabilities70,91169,58569,388
SHAREHOLDERS EQUITY
Common stock6,5936,5936,593
Additional paid-in capital11,68511,68511,685
Retained earnings (accumulated deficit)59,25453,46348,861
Treasury stock - common(18266)(18265)(17593)
Unrealized gain (loss)2,002(314)(193)
Other equity, total18,35412,2885,542
Total equity79,62365,45054,895
Total liabilities & shareholders' equity150,534135,035124,282
Total common shares outstanding444444
Treasury shares - common primary issue9.049.048.71
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.